James Allan B, Conway Ann-Marie, Morris Brian J
Division of Neuroscience and Biomedical Systems, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom.
J Neurosci. 2006 Feb 1;26(5):1624-34. doi: 10.1523/JNEUROSCI.4199-05.2006.
Most forms of neuronal plasticity are associated with induction of the transcription factor Zif268 (Egr1/Krox24/NGF-IA). In a genome-wide scan, we obtained evidence for potential modulation of proteasome subunit and regulatory genes by Zif268 in neurons, a finding of significance considering emerging evidence that the proteasome modulates synaptic function. Bioinformatic analysis indicated that the candidate proteasome Zif268 target genes had a rich concentration of putative Zif268 binding sites immediately upstream of the transcriptional start sites. Regulation of the mRNAs encoding the psmb9 (Lmp2) and psme2 (PA28beta) proteasome subunits, along with the proteasome-regulatory kinase serum/glucocorticoid-regulated kinase (SGK) and the proteasome-associated antigen peptide transporter subunit 1 (Tap1), was confirmed after transfection of a neuronal cell line with Zif268. Conversely, these mRNAs were upregulated in cerebral cortex tissue from Zif268 knock-out mice relative to controls, confirming that Zif268 suppresses their expression in the CNS. Transfected Zif268 reduced the activity of psmb9, SGK, and Tap1 promoter-reporter constructs. Altered psmb9, SGK, and Tap1 mRNA levels were also observed in an in vivo model of neuronal plasticity involving Zif268 induction: the effect of haloperidol administration on striatal gene expression. Consistent with these effects on proteasome gene expression, increased Zif268 expression suppressed proteasome activity, whereas Zif268 knock-out mice exhibited elevated cortical proteasome activity. Our findings reveal that Zif268 regulates the expression of proteasome and related genes in neuronal cells and provide new evidence that altered expression of proteasome activity after Zif268 induction may be a key component of long-lasting CNS plasticity.
大多数形式的神经元可塑性都与转录因子Zif268(Egr1/Krox24/NGF-IA)的诱导有关。在全基因组扫描中,我们获得了证据,表明Zif268可在神经元中对蛋白酶体亚基和调控基因进行潜在调节,鉴于有新证据表明蛋白酶体可调节突触功能,这一发现具有重要意义。生物信息学分析表明,候选的蛋白酶体Zif268靶基因在转录起始位点上游紧邻区域富含假定的Zif268结合位点。在用Zif268转染神经元细胞系后,证实了编码蛋白酶体亚基psmb9(Lmp2)和psme2(PA28β)的mRNA,以及蛋白酶体调节激酶血清/糖皮质激素调节激酶(SGK)和蛋白酶体相关抗原肽转运亚基1(Tap1)的表达受到调控。相反,相对于对照组,来自Zif268基因敲除小鼠大脑皮质组织中的这些mRNA上调,证实Zif268在中枢神经系统中抑制它们的表达。转染的Zif268降低了psmb9、SGK和Tap1启动子-报告基因构建体的活性。在涉及Zif268诱导的神经元可塑性体内模型中,即氟哌啶醇给药对纹状体基因表达的影响中,也观察到了psmb9、SGK和Tap1 mRNA水平的改变。与这些对蛋白酶体基因表达的影响一致,Zif268表达增加会抑制蛋白酶体活性,而Zif268基因敲除小鼠的皮质蛋白酶体活性则升高。我们的研究结果表明,Zif268在神经元细胞中调节蛋白酶体及相关基因的表达,并提供了新的证据,即Zif268诱导后蛋白酶体活性表达的改变可能是持久的中枢神经系统可塑性的关键组成部分。